AIH for Spinal Cord Repair

NCT ID: NCT03780829

Last Updated: 2025-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-25

Study Completion Date

2026-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Contusive cervical spinal cord injury (cSCI) impairs upper limb function (reach-and-grasp) which limits daily-life activities and thus decreases the quality of life. Promoting neuroplasticity may support upper limb recovery after SCI. Repetitive exposure to acute intermittent hypoxia (rAIH) combined with motor training promotes recovery of motor function after SCI; however, the overall effects of rAIH/training are limited. The investigators will use an adult rat model of long-term contusive cSCI to study novel approaches to enhance the effect of rAIH/training on forelimb function and study the neuronal substrate underlying the effects. The findings will be used to direct the development of more effective rAIH/training approaches for people with contusive, functionally incomplete, cSCI. Because deficits in upper limb function are a major problem after stroke, amyotrophic lateral sclerosis, multiple sclerosis, and other motor disorders, this work may also be relevant for patients with other types of central nervous system (CNS) lesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The overall goal is to develop effective, clinically applicable, approaches to restore upper limb function (reach-and-grasp) after chronic contusive cervical spinal cord injury (cSCI). Impairments in upper limb function significantly reduce the quality of life for people with cSCI. Reach-and-grasp actions in animals and humans are largely controlled by the corticospinal tract (CST). The investigators argue that promoting plasticity within the CST may support the recovery of upper limb function after cSCI. Repetitive exposure to acute intermittent hypoxia (rAIH) combined with motor training is a safe, minimally invasive, treatment that elicits neuroplasticity resulting in improved recovery after cSCI, but its overall effects remain limited. The main goals are to: 1) enhance rAIH/training-induced aftereffects on forelimb function and increase the understanding of the neuronal substrates in an adult rat model of chronic contusive cSCI, and 2) use this knowledge to guide the development of more effective rAIH/training approaches to improve upper limb function in humans with chronic contusive cSCI.

In Specific Aim 1, using an adult rat model of chronic contusive cSCI, the investigators will investigate the effects of rAIH frequency and dose on rAIH/training-mediated functional recovery of the impaired forelimb. Also, the investigators will combine rAIH/training with N-methyl-D-aspartate receptor (NMDA)-mediated synaptic plasticity through D-cycloserine treatment and study the effects on recovery of forelimb function. Immunocytochemistry with imaging techniques will be used to assess structural neuronal plasticity in the CST after rAIH/training. In Specific Aim 2, in people with chronic incomplete cSCI, guided by the findings in Specific Aim 1, the investigators will study the effects of rAIH frequency and concurrent D-cycloserine treatment on rAIH/training-mediated upper limb function recovery. The investigators will comprehensively analyze the effects of rAIH on the strength of electrophysiological and functional aftereffects in the upper limb.

The proposed research will provide new knowledge on rAIH/training-mediated functional and anatomical aftereffects (Specific Aim 1), which will be used to develop effective rAIH/training protocols for people with contusive, functionally incomplete, cSCI (Specific Aim 2). The data from the investigators' experiments may lead to clinically applicable approaches that improve arm and hand function recovery after chronic contusive cSCI, which would positively impact the quality of life of Veterans with cSCI. The relevance of this proposal is emphasized by the limited efficacy of current strategies to improve upper limb function after cSCI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SCI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

repetitive intermittent hypoxia treatment combined with exercise and/or NMDA agonist
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
participants and some research personnel will be blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hypoxia plus training

combined hypoxia treatment with exercise training

Group Type EXPERIMENTAL

hypoxia

Intervention Type BEHAVIORAL

intermittent cycles of normoxia-hypoxia

exercise training

Intervention Type BEHAVIORAL

bimanual massed practice training

sham hypoxia plus training

combined sham hypoxia treatment with exercise training

Group Type SHAM_COMPARATOR

sham hypoxia

Intervention Type BEHAVIORAL

intermittent cycles of sham hypoxia

exercise training

Intervention Type BEHAVIORAL

bimanual massed practice training

hypoxia plus training plus NMDA agonist

combined hypoxia treatment with exercise training and with NMDA agonist treatment

Group Type EXPERIMENTAL

hypoxia

Intervention Type BEHAVIORAL

intermittent cycles of normoxia-hypoxia

D-cycloserine

Intervention Type DRUG

NMDA agonist treatment

exercise training

Intervention Type BEHAVIORAL

bimanual massed practice training

hypoxia plus training plus sham NMDA agonist

combined hypoxia treatment with exercise training and with sham NMDA agonist treatment

Group Type PLACEBO_COMPARATOR

hypoxia

Intervention Type BEHAVIORAL

intermittent cycles of normoxia-hypoxia

sham-NMDA agonist

Intervention Type DRUG

sham-NMDA agonist treatment

exercise training

Intervention Type BEHAVIORAL

bimanual massed practice training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hypoxia

intermittent cycles of normoxia-hypoxia

Intervention Type BEHAVIORAL

sham hypoxia

intermittent cycles of sham hypoxia

Intervention Type BEHAVIORAL

D-cycloserine

NMDA agonist treatment

Intervention Type DRUG

sham-NMDA agonist

sham-NMDA agonist treatment

Intervention Type DRUG

exercise training

bimanual massed practice training

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

NMDA agonist

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and females Veterans between 18-85 years
* Chronic cSCI (1 yr of injury)
* Cervical injury at C8 or above
* Sensory function: impaired (score of 1) but not absent (score of 0) or intact (score of 2) innervations in dermatomes C6, C7 and C8 during light touch and pin prick stimulus using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) sensory scores
* Motor function: Able to grasp small objects with one hand and able to perform a visible precision grasp between the index finger and thumb
* Motor scores ISNCSCI: 1 to 4 but not 5 on finger flexors and finger abductors on the hand tested.

* These criteria were selected to ensure that hand impairment will not interfere with the ability to perform training and proposed tests


* Male and females (18-80 years)
* Right handed
* Able to complete precision and power grips

Exclusion Criteria

* Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
* Any debilitating disease prior to the SCI that caused exercise intolerance
* Premorbid, ongoing major depression or psychosis, altered cognitive status
* History of head injury or stroke
* Metal plate in skull
* History of seizures
* Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs

* chlorpromazine
* clozapine
* or tricyclic antidepressants
* Pregnant females
* Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease as spinal stenosis, spina bifida or herniated cervical disk

* resting heart rate \> 120 bpm
* resting systolic blood pressure \>180 mmHg
* resting diastolic blood pressure \>100 mmHg
* self-reported history of unstable angina or myocardial infarction within the previous month
* resting SpO2 \> or equal to 95%
* cardiopulmonary complications such as COPD


* Same as for SCI individuals
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin Oudega, PhD

Role: PRINCIPAL_INVESTIGATOR

Edward Hines Jr. VA Hospital, Hines, IL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Edward Hines Jr. VA Hospital, Hines, IL

Hines, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Martin Oudega, PhD

Role: CONTACT

(305) 575-7000

Monica A Perez, PhD

Role: CONTACT

(312) 238-2886

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gabrielle A Mendoza, DPT

Role: primary

312-238-1629

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B2848-R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AIH-induced Walking Recovery After Subacute SCI
NCT02632422 ACTIVE_NOT_RECRUITING NA
Rebuilding Inter-limb Transfer in Cervical SCI
NCT06440538 RECRUITING EARLY_PHASE1